FDA Plans Two-Day Meeting On Off-Label Marketing
The agency will gather stakeholders in November to discuss questions about the potential broader availability of off-label medical product information. FDA is in the process of overhauling its off-label communications policies.
You may also be interested in...
Attorneys involved with a recent court ruling favoring Vascular Solutions believe the verdict might give manufacturers more latitude to engage in truthful, non-misleading, off-label speech. But caution is necessary.
The focus on innovative manufacturing will also include a new clearinghouse to share info about advanced manufacturing technology within the US agency’s device center.
The updates reflect changes to standards on medical electrical equipment and a wide range of device types.